Jump Financial, LLC - PUMA BIOTECHNOLOGY INC ownership

Quarter-by-quarter ownership
Jump Financial, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$64,935
-5.7%
24,690
+26.6%
0.00%
-33.3%
Q2 2023$68,835
-36.2%
19,500
-44.1%
0.00%
-25.0%
Q1 2023$107,841
-45.6%
34,900
-25.5%
0.00%
-63.6%
Q4 2022$198,108
+73.8%
46,834
+18.0%
0.01%
+120.0%
Q1 2022$114,000
-17.4%
39,700
-12.6%
0.01%
-44.4%
Q4 2021$138,000
-40.5%
45,400
+97.4%
0.01%
-80.9%
Q3 2020$232,00023,0000.05%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 207,500$21,609,0004.97%
WEATHERBIE CAPITAL, LLC 250,296$26,066,0002.47%
Redmile Group, LLC 172,092$17,922,0002.14%
Tekla Capital Management LLC 185,820$19,351,0001.93%
Iguana Healthcare Management, LLC 35,000$3,645,0001.68%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$592,210,0001.62%
Atika Capital Management LLC 11,350$1,182,0001.01%
Eventide Asset Management 44,900$4,676,0000.73%
Ghost Tree Capital, LLC 11,330$1,180,0000.70%
BB BIOTECH AG 117,991$12,288,0000.63%
View complete list of PUMA BIOTECHNOLOGY INC shareholders